Caisse Des Depots ET Consignations Buys New Position in The Clorox Company (NYSE:CLX)

Caisse Des Depots ET Consignations purchased a new position in The Clorox Company (NYSE:CLXFree Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,494 shares of the company’s stock, valued at approximately $243,000.

Other large investors have also modified their holdings of the company. Public Employees Retirement System of Ohio boosted its stake in Clorox by 26.3% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 59,766 shares of the company’s stock worth $9,736,000 after purchasing an additional 12,428 shares in the last quarter. Fifth Third Wealth Advisors LLC purchased a new position in shares of Clorox in the fourth quarter worth $204,000. Apollon Wealth Management LLC lifted its stake in shares of Clorox by 119.6% during the fourth quarter. Apollon Wealth Management LLC now owns 3,364 shares of the company’s stock worth $546,000 after buying an additional 1,832 shares during the period. Miracle Mile Advisors LLC purchased a new stake in shares of Clorox during the fourth quarter valued at $1,566,000. Finally, Geode Capital Management LLC increased its position in shares of Clorox by 1.1% in the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock valued at $491,713,000 after acquiring an additional 33,970 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 1.9 %

Shares of Clorox stock opened at $145.70 on Friday. The firm has a 50-day simple moving average of $151.62 and a two-hundred day simple moving average of $159.22. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The company has a market cap of $17.95 billion, a P/E ratio of 39.81, a price-to-earnings-growth ratio of 2.62 and a beta of 0.45.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the business posted $2.16 earnings per share. As a group, equities analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.35%. The ex-dividend date is Wednesday, April 23rd. Clorox’s payout ratio is presently 133.33%.

Analysts Set New Price Targets

A number of brokerages have commented on CLX. JPMorgan Chase & Co. lifted their price target on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Barclays dropped their target price on Clorox from $140.00 to $139.00 and set an “underweight” rating on the stock in a research report on Thursday. DA Davidson cut their price target on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. Evercore ISI lifted their price objective on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Three analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $159.50.

Get Our Latest Analysis on CLX

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.